BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 8143332)

  • 1. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and electroneurophysiological assessment of leprosy patients on dapsone monotherapy--a two year follow-up study.
    Rao SP; Taori GM; Desikan KV; Nayar S
    Indian J Lepr; 1995; 67(2):167-76. PubMed ID: 8537705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of three-year multidrug therapy in multibacillary leprosy patients.
    Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
    Mehta J; Gandhi IS; Sane SB; Wamburkar MN
    Indian J Lepr; 1985; 57(2):297-310. PubMed ID: 4078356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
    Singh RP; Tiwari VD; Chattopadhyay SP
    Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of nerve conduction velocity, somatosensory-evoked potential and late responses (H-reflex and F-wave) of posterior tibial nerve in leprosy.
    Gupta BK; Kochar DK
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):586-93. PubMed ID: 7868958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy. Recognition and treatment.
    Ramos-e-Silva M; Rebello PF
    Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K; Natarajan M; Bagga A; Katoch VM
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
    Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
    Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
    Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
    Ekambaram V; Rao MK
    Indian J Lepr; 1989 Jan; 61(1):31-43. PubMed ID: 2784822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
    Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; LĂ©oture A; Grosset JH; Sansarricq H
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.